Carlo Federico Perno

发表

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, P. Narciso, 2004, The Journal of infectious diseases.

Molecular Epidemiology: HIV-1 and HCV sequences from Libyan outbreak

Tulio de Oliveira, Andrew Rambaut, Oliver G. Pybus, 2006, Nature.

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

Francesco Montella, Claudia Alteri, Vanni Borghi, 2017, Journal of Clinical Microbiology.

Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution.

Valentina Svicher, Jens Verheyen, Valeria Micheli, 2013, The Journal of general virology.

Global epidemiology of drug resistance after failure of WHO recommended fi rst-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Huldrych F. Günthard, Tulio de Oliveira, Lynn Morris, 2019 .

Construction, Training and Clinical Validation of An Interpretation System for Genotypic HIV-1 Drug Resistance Based on Fuzzy Rules Revised by Virological Outcomes

Marilena Vendittelli, Giovanni Ulivi, Francesco Baldini, 2003, Antiviral therapy.

Computational analysis of Human Immunodeficiency Virus (HIV) Type-1 reverse transcriptase crystallographic models based on significant conserved residues found in Highly Active Antiretroviral Therapy (HAART)-treated patients.

Stefano Alcaro, Anna Artese, Vitaliano Chiarella, 2010, Current medicinal chemistry.

Characterization and Structural Analysis of Novel Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Involved in the Regulation of Resistance to Nonnucleoside Inhibitors

Thomas Lengauer, Stefano Alcaro, Jan Balzarini, 2007, Journal of Virology.

Identification and Structural Characterization of Novel Genetic Elements in the HIV-1 V3 Loop Regulating Coreceptor Usage

Stefano Alcaro, Giorgio Palù, Anna Artese, 2011, Antiviral therapy.

Therapeutic Drug Monitoring and Drug–Drug Interactions Involving Antiretroviral Drugs

David Back, David Burger, Charles Flexner, 2005, Antiviral therapy.

Anti-HIV Effects of Chloroquine: Inhibition of Viral Particle Glycosylation and Synergism With Protease Inhibitors

Sergio Rutella, Enrica Tamburrini, Roberto Cauda, 2004, Journal of acquired immune deficiency syndromes.

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Valentina Svicher, Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, 2005, Antimicrobial Agents and Chemotherapy.

HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors

Stefano Alcaro, Anna Artese, Lucia Parrotta, 2012, PloS one.

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment.

Stefano Bonora, Valentina Svicher, P. Narciso, 2006, The Journal of antimicrobial chemotherapy.

Key genetic elements in HIV-1 gp120 V1,V2 and C4 domains tightly and differentially modulate gp120 interaction with the CCR5 and CXCR4 N terminus and HIV-1 antigenetic Potential

Anna Artese, Lucia Parrotta, Giosuè Costa, 2011 .

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection.

Valentina Svicher, Jens Verheyen, Valeria Micheli, 2012, Antiviral research.

Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failed.

Alessandro Cozzi-Lepri, A. d’Arminio Monforte, C. Perno, 2004, The Journal of infectious diseases.

Detecting Hepatitis B Viral Amino Acid Sequence Mutations in Occult Hepatitis B Infections via Bayesian Partition Model

Yang Liu, Valentina Svicher, C. Perno, 2013 .

Novel drug resistance mutations in HIV: recognition and clinical relevance.

Valentina Svicher, Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, 2006, AIDS reviews.

HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.

Jeroen Aerssens, Valentina Svicher, Loredana Sarmati, 2011, Antiviral research.

Drug-Class-Wide Resistance to Antiretrovirals in HIV-Infected Patients Failing Therapy: Prevalence, Risk Factors and Virological Outcome

P. Narciso, A. Antinori, V. Tozzi, 2005, Antiviral therapy.

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Alessandro Cozzi-Lepri, M. Moroni, F. Chiodo, 2004, AIDS.

Antiviral Efficacy and Genotypic Resistance Patterns of Combination Therapy with Stavudine/Tenofovir in Highly Active Antiretroviral Therapy Experienced Patients

Stefano Bonora, Stefania Merli, Massimo Andreoni, 2006, Antiviral therapy.